



▲ Xu Chuan The professor came to the stage to receive the award
Among the first prize lists for the 2025 Sichuan Provincial Science and Technology Progress Award, the "Key Technology Innovation, Promotion and Application of Precision Immunotherapy for Lung Cancer" project is among them. This project was jointly completed by the Cancer Center of Sichuan Provincial People's Hospital and the team of Professor Xu Chuan from Jinfeng Laboratory and Chongqing-Guangdong Pathological Science Research Center. This achievement not only comes from the research of a single team, but also a vivid practice of cross-domain integration and collaborative construction of scientific and technological resources in Chengdu and Chongqing.
Complement each other's advantages and open up an innovation chain. Chongqing focuses on pathological mechanism research, while Chengdu focuses on clinical translation research and follow-up data. After the inauguration of Jinfeng Laboratory, Xu Chuan settled in the laboratory as a part-time project leader and led the "Lung Cancer Heterogeneity and Personalized Intelligent Diagnosis and Treatment Research Team" to take root in Jinfeng. The Chengdu end provides real patient cohort and clinical endpoint data, while the Chongqing end relies on the pathological phenotype platform to carry out protein purification, single cell and spatial multi-omics analysis and AI screening. Samples, data and mechanism research flowed in real time between the two places, changing the previous collaboration method of "each working on a piece and then splicing it together". In February 2025, the construction of the Sichuan-Chongqing Key Laboratory of Pathological Testing and Diagnosis was approved. Jinfeng Laboratory cooperates with the Army Medical University, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, the First Affiliated Hospital of Chongqing Medical University and other units to jointly tackle key problems and break through the blocking points of "clinical discovery - pathological mechanism - industrial transformation" one by one.

▲“ Key technological innovation, promotion and application of precision immunotherapy for lung cancer ”Project innovation contribution
Jointly tackle key problems and produce a batch of original results . The team pioneered the "source-network" immune escape theory to reveal the "invisibility cloak" recurrence mechanism of tumors. ; Construct a visual early warning and immune escape intervention technology system ; A new integrated diagnosis and treatment model of "population stratification, individual assessment, precise treatment, and new drug research and development" has been formed. The results have been accumulated continuously for fifteen years and transformed intensively for three years: the relevant academic views have been cited 4976 times by Cell, Nat Med, Lancet Oncol and other journals. ; Obtained 2 Category 1.1 new drug approvals and developed 8 test kits ; Jointly developed a "high-precision cancer stem cell intelligent capture flow cytometer" and obtained a Class II medical device registration certificate. It has been implemented on a large scale in top tertiary hospitals, universities and pharmaceutical companies across the country. ; Relevant technologies have been promoted and applied in hundreds of medical institutions across the country.
mechanism Build together to form a set of scientific research paradigms . From "sharing platform" to "co-building laboratory", Jinfeng Laboratory uses the "task list system" to transform real clinical problems into hard scientific research tasks. Xuchuan team members often travel back and forth between Chengdu and Chongqing every month. They are on the road and are connected by a collaboration mechanism: two-way use of talents, two-way verification of data, and two-way transformation of results. The combination of Chongqing's "pathological depth" and Chengdu's "clinical breadth" promotes accurate tumor identification and effective intervention, and also promotes Sichuan-Chongqing collaborative innovation from "physical superposition" to "chemical reaction". The feasible path for the integration of scientific and technological resources in Chengdu and Chongqing has been confirmed, and a set of scientific research paradigms have been formed.
In the next step, the laboratory will continue to deepen its collaboration with Sichuan Provincial People's Hospital, Tianfu Jincheng Laboratory, etc., coordinate the use of high-quality scientific and technological innovation resources, and help the Chengdu-Chongqing region build a scientific and technological innovation center with national influence. With the practical achievements of cross-regional collaborative innovation, it will actively contribute to the construction of a healthy China and a strong scientific and technological country.